SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-147572
Filing Date
2024-05-28
Accepted
2024-05-28 06:51:29
Documents
8
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d830512d6k.htm 6-K 13031
2 EX-99.1 d830512dex991.htm EX-99.1 4107
3 EX-99.2 d830512dex992.htm EX-99.2 7457
4 EX-99.3 d830512dex993.htm EX-99.3 1584
5 EX-99.4 d830512dex994.htm EX-99.4 60164
6 EX-99.5 d830512dex995.htm EX-99.5 84163
7 GRAPHIC g830512g0525010556839.jpg GRAPHIC 2996
8 GRAPHIC g830512g0525011621706.jpg GRAPHIC 2356
  Complete submission text file 0001193125-24-147572.txt   179329
Mailing Address GOTTLIEB-DAIMLER-STRASSE 2 MANNHEIM 2M 68165
Business Address GOTTLIEB-DAIMLER-STRASSE 2 MANNHEIM 2M 68165 49-621-560030
Affimed N.V. (Filer) CIK: 0001608390 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36619 | Film No.: 24986232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)